# Amylyx Pharmaceuticals, Inc.: Form DEF 14A, filed Apr 24, 2024

- Company: [Amylyx Pharmaceuticals, Inc.](/companies/amlx.md) (CIK 1658551)
- Form: DEF 14A
- Filed: 2024-04-24
- Accepted by EDGAR: Apr 24, 2024, 11:07 ET
- Period: 2024-06-06
- Accession: 0000950170-24-047243
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1658551/000095017024047243/amlx-20240424.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1658551/000095017024047243/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1658551/000095017024047243/amlx-20240424.htm

Filed Apr 24, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-047243. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.